Palomino Laboratories Inc. (PALX) shareholders
Close on Oct 15, 2026Market cap $305.46MP/E –Yield –
Ownership
Who owns Palomino Laboratories's shares
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Matthew Eitner Joint filing with Lucius Partners LLC (100.00%) | 5,000,000 | 100.00% | 13D (active) | Oct 9, 2023 |
| Shealy Jeffrey B. | 4,666,666 | 23.80% | 13D (active) | Sep 29, 2025 |
| Richard Ogawa | 1,882,500 | 6.90% | 13D (active) amendment | Jul 31, 2026 |
| Steven DenBaars | 1,750,000 | 9.40% | 13D (active) | Sep 29, 2025 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Richard Ogawa | Secretary, Director | 1,882,500 | 6.81% | Aug 4, 2026 |
| Jeffrey B. Shealy | President and CEO, Director, 10% owner | 4,666,666 | 16.89% | Oct 27, 2025 |
| Jason Tu | Chief Accounting Officer | 125,001 | 0.45% | Oct 9, 2025 |
| Steven Denbaars | Director | 1,762,500 | 6.38% | Apr 20, 2026 |
| Partners LLC Lucius | 10% owner | 4,000,000 | 14.47% | Oct 2, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Richard Ogawa Secretary, Director | Jul 31, 2026 | Other | +120,000 | $5.14 | $616.80K | 1,882,500 |
| Steven Denbaars Director | Apr 20, 2026 | Buy | +12,500 | $4.00 | $50.00K | 1,762,500 |
| Richard Ogawa Secretary, Director | Apr 20, 2026 | Buy | +12,500 | $4.00 | $50.00K | 1,762,500 |
| Jeffrey B. Shealy President and CEO, Director, 10% owner | Sep 29, 2025 | Other | +3,833,333 | – | – | 4,666,666 |
| Jason Tu Chief Accounting Officer | Sep 29, 2025 | Other | +83,334 | – | – | 125,001 |
| Richard Ogawa Secretary, Director | Sep 29, 2025 | Other | +1,625,000 | – | – | 1,750,000 |
| Steven Denbaars Director | Sep 29, 2025 | Other | +1,625,000 | – | – | 1,750,000 |
| Partners LLC Lucius 10% owner | Sep 29, 2025 | Other | −1,000,000 | – | – | 4,000,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 15, 2026 (FINRA, reported twice a month)
Shares sold short, last 2 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Palomino Laboratories's stock actually held short. Settlement fails (shares not delivered on time) peaked at 292 shares on Sep 29, 2026 over the last 90 days.
See a number that looks wrong?